会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Mixed ligand complexes and uses thereof as binding agents to DNA
    • 混合配体配合物及其作为DNA结合剂的用途
    • US5439794A
    • 1995-08-08
    • US843315
    • 1992-02-28
    • Jacqueline K. Barton
    • Jacqueline K. Barton
    • C07D471/04C07F3/00C07F15/00C07F15/06C07H21/00C07H23/00C12Q1/68C07H21/04C07H21/02
    • C07H21/00C07D471/04C07F15/0013C07F15/0053C07F15/008C07F15/065C07F3/003C07H23/00C12Q1/68C12Q1/6816
    • This invention concerns a coordination complex or salt thereof which is spectroscopically or photoactively determinable when bound to DNA having the formula ##STR1## wherein M is a suitable transition metal and each of R.sub.1, R.sub.2 and R.sub.3 is ethylenediamine or a substituted derivative thereof, bipyridine or a substituted derivative thereof, phenanthroline or a substituted derivative thereof, diazfluorene-9-one or a substituted derivative thereof, phenanthrenequinonediimine or a substituted derivative thereof; wherein R.sub.1, R.sub.2 and R.sub.3 are bound to M by coordination bonds wherein R.sub.1 and R.sub.2 are the same and both are different from R.sub.3. The invention also concerns a method of labeling DNA with the coordination complex, a DNA molecule labeled with the coordination complex, a method of selectively labeling DNA conformation with the coordination complex and a method of detecting the presence of a conformation present in a double stranded DNA.
    • 本发明涉及一种配位络合物或其盐,当与结合式为“IMAGE”的DNA结合时,其光谱或光活性可确定,其中M为合适的过渡金属,R 1,R 2和R 3各自为乙二胺或其取代的衍生物,联吡啶或 取代衍生物,菲咯啉或其取代的衍生物,二氮杂芴-9-酮或其取代衍生物,菲醌亚胺或其取代的衍生物; 其中R1,R2和R3通过配位键与M结合,其中R 1和R 2相同并且两者都不同于R 3。 本发明还涉及用配位络合物标记DNA的方法,用配位络合物标记的DNA分子,用配位络合物选择性标记DNA构象的方法和检测双链DNA中存在的构象的方法 。
    • 4. 发明授权
    • Detection and treatment of duplex polynucleotide damage
    • 检测和处理双链多核苷酸损伤
    • US06306601B1
    • 2001-10-23
    • US09447447
    • 1999-11-22
    • Jacqueline K. BartonBrian A. JacksonBrian P. Hudson
    • Jacqueline K. BartonBrian A. JacksonBrian P. Hudson
    • C12Q168
    • C07F15/008
    • Duplex polynucleotides containing damage or errors are detected with hindered intercalating compounds which are capable of intercalating only in the presence of such damage or error. Conditions characterized by the presence of polynucleotide errors or damage are treated with such compounds that are capable of catalyzing polynucleotide cleavage with light. Suitable compound include compounds of the formula: Rh(R1)(R2)(R3)3+ where R1 and R2 are each indepenently aryl, heteroaryl, substituted aryl or substituted heteroaryl of 1 to 5 rings, and R3 is a group of the formula where x and z are each independently an interger from 1 to 4 and y is an interger from 1 to 2, and R4, R5, and R6 are independently H—, halo, HO—, H2N—, CN—, O2N—, HS—, O3S—, O3SO—, —COOH, —CONH2, R, RO—, RNH—, RaRbN—, RO3SO—, RO3SO—, —COOR, —CONHR, or —CONHRaRbwhere R, Ra and Rb are each independently lower alkyl, cycloalkyl, lower alkenyl, lower alkynyl, or phenyl, or two R4, R5, or R6 together form a fused aryl ring.
    • 含有损伤或错误的双链多核苷酸用受阻的插入化合物检测,只能在存在这种损伤或错误的情况下插入。 以多核苷酸错误或损伤存在为特征的条件用能够用光催化多核苷酸切割的化合物处理。 合适的化合物包括下式的化合物:其中R 1和R 2各自独立地为1至5个环的芳基,杂芳基,取代的芳基或取代的杂芳基,并且R 3是式的基团,x和z各自独立地为1至4的整数 并且y是1至2的整数,R4,R5和R6独立地为H,卤素,HO-,H2N-,CN-,O2N-,HS-,O3S-,O3SO-,-COOH,-CONH2 ,R,RO-,RNH-,RaRbN-,RO3SO-,RO3SO-,-COOR,-CONHR或-CONHRaRb,其中R,Ra和Rb各自独立地为低级烷基,环烷基,低级烯基,低级炔基或苯基,或 两个R 4,R 5或R 6一起形成稠合的芳基环。
    • 6. 发明授权
    • Mixed ligand complexes and uses thereof as binding agents and probes to
DNA
    • 混合配体配合物及其作为结合剂和DNA探针的用途
    • US5157032A
    • 1992-10-20
    • US539930
    • 1990-06-18
    • Jacqueline K. Barton
    • Jacqueline K. Barton
    • C07D471/04C07F15/06C07H21/00C07H23/00C12Q1/68
    • C07D471/04C07F15/065C07H21/00C07H23/00C12Q1/68C12Q1/6816Y10S514/885
    • This invention concerns a coordination complex or salt thereof which is spectroscopically or photoactively determinable when bound to DNA having the formula ##STR1## wherein M is a suitable transition metal and each of R.sub.1, R.sub.2 and R.sub.3 is ethylenediamine, bipyridine, phenanthroline, diazafluorene-9-one or a substituted derivative thereof, or phenanthrenequinonediimine or a substituted derivative thereof, dypyridophenazine or a substituted derivative thereof; wherein R.sub.1, R.sub.2 and R.sub.3 are bound to M by coordination bonds; provided that at least one of R1, R2 or R3 is dypyridophenazine or a substituted derivative thereof. The invention also concerns a labeled DNA probe which comprises the complex covalently bound to the DNA probe. Further the invention concerns a method of detecting the presence in a sample a target DNA of interest which comprises contacting the sample containing the target DNA with a complementary labeled DNA probe under hybridizing conditions and measuring the resulting luminescense emitted from the labeled DNA probe, a change in the luminescense as compared with the luminescense in the absence of the sample indicating the presence of the target DNA.
    • 本发明涉及一种配位络合物或其盐,其在与具有式IMA的DNA结合时光谱或光活性可测定,其中M为合适的过渡金属,R 1,R 2和R 3各自为乙二胺,联吡啶,菲咯啉,二氮杂芴-9 或其取代衍生物,或菲醌亚胺或其取代衍生物,二吡啶并吩嗪或其取代的衍生物; 其中R1,R2和R3通过配位键与M结合; 条件是R 1,R 2或R 3中的至少一个是二吡啶并吩嗪或其取代的衍生物。 本发明还涉及标记的DNA探针,其包含共价结合DNA探针的复合物。 此外,本发明涉及一种检测样品中存在感兴趣的靶DNA的方法,其包括在杂交条件下使包含靶DNA的样品与补体标记的DNA探针接触,并测量从标记的DNA探针发射的所得发射亮度,变化 在不存在样品表明靶DNA存在的情况下与发光相比较。
    • 7. 发明授权
    • Site-specific chiral ruthenium (II) and cobalt (III) antitumor agents
    • 位点特异性手性钌(II)和钴(III)抗肿瘤剂
    • US4699978A
    • 1987-10-13
    • US693019
    • 1985-01-18
    • Jacqueline K. Barton
    • Jacqueline K. Barton
    • C07F15/00C07F15/06C12Q1/68A61K33/24C07D471/04C07H21/00
    • C12Q1/68C07F15/0053C07F15/065C12Q1/6816
    • This invention concerns a coordination complex of the formula (R).sub.2 --M--(Y).sub.2 wherein M comprises a suitable transition metal, e.g. cobalt or ruthenium, R comprises 1,10-phenanthroline or a substituted derivative thereof, Y comprises a labile ligand, e.g. chloride, tartrate, malonate or ascorbate ion and R and Y are bonded to M by coordination bonds.A complex of this invention may be used for covalently labeling DNA with a complex of the formula (R).sub.2 --M, wherein R and M are as previously defined. A complex of this invention which contains cobalt may also be used in a method for nicking DNA by effecting single-stranded scission of at least one phosphodiester bond of the DNA with ultraviolet radiation.A complex of this invention is further useful in a method for killing tumor cells. A pharmaceutical composition for the treatment of tumor cells in a subject may be prepared containing an effective anti-tumor amount of a complex of this invention and a pharmaceutically acceptable carrier. Such a composition may be used for treating a subject afflicted with tumor cells so as to cause regression of the tumor cells.
    • 本发明涉及式(R)2-M-(Y)2的配位络合物,其中M包括合适的过渡金属,例如 钴或钌,R包括1,10-菲咯啉或其取代衍生物,Y包括不稳定的配体,例如, 氯化物,酒石酸盐,丙二酸盐或抗坏血酸盐离子,R和Y通过配位键与M键合。 本发明的复合物可用于与式(R)2-M的复合物共价标记DNA,其中R和M如前所定义。 含有钴的本发明的复合物也可以用于通过用紫外线辐射进行DNA的至少一个磷酸二酯键的单链断裂来切割DNA的方法。 本发明的复合物还可用于杀死肿瘤细胞的方法。 可以制备用于治疗受试者中的肿瘤细胞的药物组合物,其含有有效的抗肿瘤量的本发明的复合物和药学上可接受的载体。 这样的组合物可以用于治疗患有肿瘤细胞的受试者,以使肿瘤细胞消退。